In addition, DLBCL/HGBCL‐MYC/BCL2 bears characteristic mutation signatures including pathogenic changes associated with classic FL as well as those associated with high‐grade transformation, serving as a robust genetic basis for differential diagnosis [8, 9, 10, 11, 12]. Here, MYC is linked to diffuse large B-cell lymphoma.